1418 / 1835
Eligibility
Disease: rel/ref HL
Stage: early/early (dx/relapse)
Tx: <6c chemotherapy
RT: none or relapse out of field
Exclusion
:
Advanced stage (dx
or
relapse
Tx: 6c chemotherapy
In-field relapse
B symptoms or bulky disease
Pembrolizumab 200 mg q3w x4
PET-Sim
PET-Sim
(within 14-21d)
D1-3
D4-5 w/o new sites
Responding on CT
New lesions
POD on CT
30 Gy
Biopsy
Off Study
36-40 Gy
30 Gy
Neg
Pos
ISRT
EOT PET
4-6w